The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 11, 2019

Filed:

Apr. 11, 2013
Applicant:

Bioverativ Therapeutics Inc., Waltham, MA (US);

Inventors:

Zoran Sosic, Cambridge, MA (US);

Andrew Blum, Wilmington, MA (US);

Bing Guan, Needham, MA (US);

Boris Boumajny, Northborough, MA (US);

Assignee:

Bioverativ Therapeutics Inc., Waltham, MA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 30/60 (2006.01); C08B 37/00 (2006.01); C08B 37/02 (2006.01); G01N 30/02 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
G01N 30/60 (2013.01); C08B 37/0003 (2013.01); C08B 37/0021 (2013.01); C08B 37/0063 (2013.01); G01N 33/6842 (2013.01); G01N 2030/027 (2013.01); G01N 2400/40 (2013.01);
Abstract

In one aspect, the disclosure provides methods of distinguishing a glycosaminoglycan from one or more other components in a sample by subjecting the sample to size-exclusion chromatography using a mobile phase having a pH of 6.8 or lower. A mobile phase having a pH of 6.8 or lower is found to improve the separation of glycosaminoglycans from proteins during size exclusion chromatography. In some embodiments, improved separation is due to the low pH of the mobile phase causing elution of less dispersed fractions of the protein and/or glycosaminoglycan. In some embodiments, the overlap between protein and/or glycosaminoglycan fractions is reduced.


Find Patent Forward Citations

Loading…